Theriva Biologics (TOVX) Other Operating Expenses (2010 - 2024)
Theriva Biologics (TOVX) posted quarterly Other Operating Expenses of $2.9 million for Q3 2024, down 29.92% quarter-over-quarter from $4.1 million in Q2 2024.
Theriva Biologics (TOVX) Other Operating Expenses (2010 - 2024) Analysis & Trends
Theriva Biologics (TOVX) has reported Other Operating Expenses for 4 consecutive years, with $2.9 million the latest figure, recorded in Q3 2024.
- In Q3 2024, Other Operating Expenses changed N/A year-over-year to $2.9 million; the TTM figure through Jun 2025 stood at $2.9 million (down 29.92% YoY), while the FY2024 annual figure was $6.9 million, changed N/A from the prior year.
- Other Operating Expenses declined to $2.9 million in Q3 2024 per TOVX's latest filing, from $4.1 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $4.1 million in Q2 2024 and bottomed at $2.9 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Theriva Biologics | 10.64 Mn | 10.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2.85 Mn |
| Jun 30, 2024 | 4.07 Mn |
| Dec 31, 2012 | 4.49 Mn |
| Mar 31, 2011 | -5,000.00 |
| Dec 31, 2010 | -430,001.00 |
| Sep 30, 2010 | 192,176.00 |
| Jun 30, 2010 | 132,406.00 |